2022-RA-1277-ESGO Correlation between CA125 levels & surgical findings in patients undergoing secondary operations for epithelial ovarian cancer. (20th October 2022)

• Record Type: Journal Article
• Authors: Jellali, Amani; Bouhani, Malek; Chalouati, Takoua; Sakhri, Saida; Mbarek, Mehdi; Sahraoui, Ghada; Bouaziz, Hanen; Slimane, Maher; Rahal, Khaled
• Is Part Of: International journal of gynecological cancer. Volume 32(2022)Supplement 2
• Page Start: A316
• Page End: A317
• Publication Date: 2022-10-20
• Subjects: Generative organs, Female -- Cancer -- Periodicals; 616.99465
• DOI: 10.1136/ijgc-2022-ESGO.675
• Languages: English
• ISSNs: 1048-891X

Abstract

Abstract : Introduction/Background: We aim to correlate serum CA 125 values after chemotherapy with clinical findings during second-look surgery. Methodology: This study was conducted on twenty-five patients with epithelial ovarian cancers undergoing second-look operations in our hospital between 2019 and 2021. Results: The average age of the patients was 59, 2 years. Twenty-one cases of stage III (84%) and 4 cases of stage VI (16%) high serous ovarian carcinoma. The CA125 level before chemotherapy was high in all cases with a mean rate of 932, 8 UI/ml. All the patients underwent multiple courses of neoadjuvant chemotherapy. The evaluation of response was clinically, radiologically, and biologically. Eight patients who had negative second-look findings gave normal serum CA125 levels. Of the 17 patients who were positive in second-look surgery, 10 had normal CA125 levels with a false negative rate of 58, 8%. Of the patients with normal CA125 levels at the time of operation, those with persistent disease had higher mean CA125 levels (22, 21 UI/ml) than those with no disease detected (12, 2 UI/ml). All the seven patients with elevated CA125 serum levels were positive in their second-look. 70% of patients with residual tumors having the greatest diameter less than or equal to 2 cm had normal CA125 with a mean value of 21 u/ml. 42% of patients with tumors having the greatest diameter greater than 2 cm had normal CA125, while all the 8 patients with no macroscopic tumor during surgery had normal CA125 level. These results show that the residual tumor size found in the second-look was related to the serum CA125 level. Conclusion: As CA125 levels within normal limits gave more false negatives, the necessity of second-look surgery can not be judged by serum CA125 assay though elevated CA125 levels do predict the presence of tumor.